Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023

KOLs to provide insight and discussion of HPN328 targeting SCLC, NEPC and other neuroendocrine tumors Abstract with HPN328 interim data accepted for poster presentation at the European Society for...

Related Keywords

Erin Schenk ,Maria Yonkoski ,Himisha Beltran ,Roberth Uhl ,Division Of Medical Oncology ,Nasdaq ,European Society For Medical Oncology ,University Of Colorado Anschutz Medical Campus ,Harpoon Therapeutics Inc ,Harvard Medical School ,Dana Faber Cancer Institute ,Exchange Commission ,European Society ,Medical Oncology ,New York ,Associate Professor ,Harvard Medical ,Assistant Professor ,Colorado Anschutz Medical ,Investor Relations ,Activating Construct ,Harpoon Therapeutics ,Private Securities Litigation Reform Act ,Harpoon Therapeutic ,Markets ,